Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children. (Q50313773)

2 March 2018

title

Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children. (English)

1 reference

2 March 2018

0 references

0 references

0 references

1 reference

Cazzullo AG

1

1 reference

2 March 2018

Musetti MC

2

1 reference

2 March 2018

Musetti L

3

1 reference

2 March 2018

Bajo S

4

1 reference

2 March 2018

Sacerdote P

5

1 reference

2 March 2018

Panerai A

6

1 reference

2 March 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

2 March 2018

European Neuropsychopharmacology

published in

1 reference

2 March 2018

volume

9

1 reference

2 March 2018

page(s)

361-366

1 reference

2 March 2018

issue

4

1 reference

2 March 2018

The Behavioral Summarized Evaluation: validity and reliability of a scale for the assessment of autistic behaviors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Sensitivity and specificity of the Behavioral Summarized Evaluation (BSE) for the assessment of autistic behaviors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Beta-endorphin and cholecystokinin 8 concentrations in peripheral blood mononuclear cells of autistic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Naltrexone in autistic children: behavioral symptoms and attentional learning

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

CSF beta-endorphins in childhood neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Naltrexone decreases self-injurious behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Speculations on similarities between autism and opiate addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Brief report: a double-blind study of naltrexone in infantile autism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Comparison of the effects of beta-endorphin and morphine on exploratory and socio-sexual behaviour in the male rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

CSF beta-endorphin levels in pediatric neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Neuropeptides and social behavior of rats tested in dyadic encounters

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

β-endorphin concentration in the brain of intact and hypophysectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Plasmaβ-Endorphin,β-Lipotropin, and Met-Enkephalin Concentrations during Pregnancy in Normal and Drug-Addicted Women and Their Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

A neurochemical theory of autism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Endogenous opioids and social behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Brief report: A synopsis of an open-trial of naltrexone treatment of autism with four children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Brain opioids and autism: an updated analysis of possible linkages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Brief report: plasma beta-endorphin and cortisol levels in autistic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

A case report of naltrexone treatment of self-injury and social withdrawal in autism.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

Placebo-controlled acute dosage naltrexone study in young autistic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900010-3

7 January 2021

10.1016/S0924-977X(99)00010-3

Identifiers

DOI

1 reference

2 March 2018

PubMed ID

10422898

1 reference

2 March 2018